RAPA-201 Therapy of Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Breast Cancer|Small Cell and Non-small Cell Lung Cancer|Triple Negative Breast Cancer|Gastric Cancer|Esophageal Adenocarcinoma|Gastric Junction Adenocarcinoma|Esophageal Squamous Cell Carcinoma|Head and Neck Cancer|Squamous Cell Carcinoma of Oral Cavity|Squamous Cell Carcinoma of Larynx|Squamous Cell Carcinoma of Nasopharynx|Squamous Cell Carcinoma of Other Specified Sites of Skin|Carcinoma of Unknown Primary|Bladder Cancer|Malignant Melanoma
Interventions: BIOLOGICAL: RAPA-201 Rapamycin Resistant T Cells|DRUG: Chemotherapy Prior to RAPA-201 Therapy
Sponsor: Rapa Therapeutics LLC